Viewing Study NCT00413959


Ignite Creation Date: 2025-12-24 @ 3:03 PM
Ignite Modification Date: 2026-01-25 @ 6:52 PM
Study NCT ID: NCT00413959
Status: TERMINATED
Last Update Posted: 2018-09-19
First Post: 2006-12-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: VELCADE,Rituximab,Cyclophosphamide and Decadron
Sponsor: Oncology Specialists, S.C.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Non-Hodgkin View
None Lymphoma, B-Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NHL View